Category: Covid -19

* Bengaluru firm Strides Pharma Science to launch oral drug to fight Covid

n a statement, Strides said it will “immediately launch” its generic Molnupiravir, indicated for high-risk adult patients with Covid under the brand Stripiravir.

Bengaluru pharma company Strides Pharma Science Limited said that it has received Emergency Use Authorisation from the Drug Controller General of India (DCGI) to launch Molnupiravir, an oral medication for Covid-19 in India.

In a statement, Strides said it will “immediately launch” its generic Molnupiravir, indicated for high-risk adult patients with Covid under the brand Stripiravir. The company is commercialising the product with a group-integrated supply chain for active pharmaceutical ingredients and solid oral dosage from its large-scale WHO pre-qualified manufacturing capacities, the company stated.

* Azim Premji Foundation, Salesforce to launch app to accelerate Covid-19 vaccination

‘To cover 110 million people in 25 States by June 2022’

Salesforce, a customer relationship management player, and Azim Premji Foundation have entered into a collaboration to introduce VaxIT, an app to help accelerate Covid-19 vaccination in India.

The programme would use VaxIT across 25 States to cover a population of 110 million (11 crore) across over 3,500 Primary Healthcare Centres (PHCs) by June 2022.

The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, would capture the status of vaccination to help individuals plan and stay updated on their progress in the healthcare programme. VaxIT is available on the Android app store and offers multi-lingual, and offline capabilities.

* NCBS, Tata Institute of Genetics and Society announce institutional alliance

“This engagement with the TIGS is a wonderful opportunity for NCBS researchers to engage with questions that concern both genetics and society, and at the same time broadening the collaborative footprint of the TIGS at the Bangalore Life Science Cluster,” said NCBS director Satyajit Mayor.

TIGS director Rakesh Mishra said by joining hands with the NCBS, the TIGS brings top-quality science closer to addressing societal problems in the domain of rare genetic diseases, infectious diseases and nutrition, using cutting-edge science and technology.

November 01st, 2021 – First Post – Karnataka Rajotsava Day –